Biogen announces job cuts, turns focus to Alzheimer's drug launch
said on Tuesday it expects to slash about 1,000 jobs, or 11% of its workforce, in a fresh round of cost-cutting as it looks to the launch of a new Alzheimer's drug to help it return to growth. The company said its costs are elevated compared to rivals and that it would focus on higher-growth…
#biogeninc #leqembi #tecfidera #spinraza #roche #biogen #sanofi #bmocapitalmarkets #evanseigerman #manasmishra